NCT05170334 2025-10-01Binimetinib Plus Belinostat for Subjects With Metastatic Uveal MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Active not recruiting7 enrolled
NCT05415072 2025-07-20A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant MelanomasNovartisPhase 1/2 Active not recruiting66 enrolled